Miyatake S, Bilan PJ, Pillon NJ, Klip A. Contracting C2C12 myotubes release CCL2 in an NF-B-dependent manner to induce monocyte chemoattraction. Am J Physiol Endocrinol Metab 310: E160 -E170, 2016. First published November 10, 2015; doi:10.1152/ajpendo.00325.2015.-Muscle inflammation following exercise is characterized by expression of inflammatory cytokines and chemokines. Exercise also increases muscle macrophages derived from circulating monocytes. However, it is unknown whether muscle cells themselves attract circulating monocytes, or what is the underlying mechanism. We used an in vitro system of electrical stimulation (ES) causing C 2C12 myotube contraction to explore whether monocyte chemoattraction ensues and investigated the mediating chemoattractants. Conditioned medium from ES-contracted myotubes caused robust chemoattraction of THP-1 monocytes across Boyden chambers. Following ES, expression of several known monocyte chemokines [C-C motif ligand 2 (CCL2) and C-X-C motif ligand (CXCL)1, -2, and -5] was elevated, but of these, only recombinant CCL2 effectively reproduced monocyte migration. Electrically stimulated myotubes secreted CCL2, and neutralization of CCL2 in conditioned medium or antagonizing the CCL2 receptor (CCR2) in THP-1 monocytes inhibited ES-induced monocyte migration. N-benzyl-p-toluene sulfonamide (BTS), a myosin II-ATPase inhibitor, prevented ES-induced myotube contraction but not CCL2 gene expression and secretion. The membrane-permeant calcium chelator BAPTA-AM reduced ESinduced CCL2 secretion. Hence, electrical depolarization, rather than mechanical contraction, drives the rise in CCL2, with partial calcium input. ES activated the NF-B pathway; NF-B inhibitors reduced ES-induced CCL2 gene expression and secretion and repressed ESinduced THP-1
EXERCISE INDUCES INFLAMMATORY and stress signaling in muscle, including NF-B and JNK activation (17, 39) . These pathways drive the expression of proinflammatory genes such as IL-6 and chemokines such as chemokine C-C motif ligand 2 (CCL2)/monocyte chemoattractant protein-1 (MCP-1), and chemokine C-X-C motif ligands 1 and 5 (CXCL1/5) (23, 33, 39, 43, 44) . Moreover, IL-6, CCL2, and CXCL1 rise in the circulation during exercise (5, 22) , but the cellular source is unknown. These cytokines are also secreted from contracted mouse C 2 C 12 myotubes (8, 22) and cultured primary human myotubes (32, 36, 37) , suggesting the possibility that muscle cells may be a direct source of circulating chemoattractants in response to exercise. As Pedersen and Febbraio proposed, "myokines" (defined as cytokines and other peptides that are produced and released by muscle fibers) may exert autocrine, paracrine, or endocrine effects (28) . Contracted myotubes also release ATP and other nucleotides through pannexin-1 nucleotide release channels (4) . However, the function of these released chemokines and nucleotides in the context of muscle contraction is unknown.
CCL2 and ATP are known monocyte chemoattractants (30) , and postexercised skeletal muscle presents elevated numbers of macrophages and other immune cells, dependent on the intensity and type of exercise (16, 27, 31, 46) . Depletion of circulating monocytes via clodronate-containing liposome injection in mice reduced contraction-induced accumulation of macrophages in mouse skeletal muscle without affecting the number of resident macrophages in noncontracted muscles (16) . This finding suggests that the rise in macrophage numbers in contracted muscle tissue arises from infiltration of monocytes from the circulation (instead of or in addition to proliferation of resident macrophages). However, the nature of monocyte chemoattractants emitted by contracting skeletal muscle is unresolved. We and others have found that conditions such as muscle repair, obesity, or diabetes also elevate macrophage content in mouse and human skeletal muscles (9, 10, 21) . Interestingly, during muscle injury (18) or diet-induced obesity (9) , muscle tissue macrophages are lower in CCL2 knockout mice than in wild type counterparts. Whether CCL2 itself or other factors responding to CCL2 availability are the chemoattracting agent is unknown and difficult to discern by in vivo studies. Indeed, in palmitate-challenged cultured myotubes, nucleotides such as ATP and UTP released through pannexin channels, rather than secreted chemokines, exert chemoattraction on THP-1 monocytes (30) .
Discerning the nature of the chemoattracting agent(s) can thus benefit from analysis in cell culture models. Moreover, these model systems can identify whether muscle cells have an autonomous ability to chemoattract nucleotides, by avoiding the contribution to the chemoattraction process by other muscle tissue entities (e.g., resident immune cells, pericytes, adipose and endothelial cells). Therefore, we hypothesized that contracted skeletal myotubes themselves respond to contractile stimuli by secreting chemokines and/or nucleotides that may attract monocytes. We report that C 2 C 12 myotubes contracted by electrical stimulation (ES) have chemoattracting activity toward monocytes. We identify that the major secreted chemoattractant is CCL2 and that its expression and secretion are dependent on muscle depolarization rather than contractile activity and controlled by an NF-B-regulated pathway.
MATERIALS AND METHODS
Reagents and materials. Recombinant CCL2, CXCL1, -2, -5, and -12 were from PeproTech (Rock Hill, NJ). CCL2 and IgG antibodies were from Biolegend (San Diego, CA). SP600125 was from Enzo Life Sciences (Farmingdale, NY). N-benzyl-p-toluene sulfonamide (BTS) was from Toronto Research Chemicals (Toronto, ON, Canada). Bis(2-aminophenoxy)ethane-tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA-AM) was from ThermoFisher/Invitrogen (Mississauga, ON, Canada). Cardamonin and caffeic acid phenethyl ester were from Tocris Bioscience (Bristol, UK). Carbachol, proteinase K, RS102895, and AMD3100 were from Sigma-Aldrich (Mississauga, ON, Canada). Sample concentrators with a 3-kDa cut-off membrane were from GE Healthcare (Mississauga ON, Canada). Tissue culture media and serum were from Wisent Bio Products (St-Bruno, QC, Canada).
Cell culture. THP1 monocytes were grown in RPMI 1640 containing 5% FBS and 1% penicillin-streptomycin. C 2C12 myoblasts were seeded on six-well plates at a density of 3 ϫ 10 5 cells/well with 2 ml of growth medium consisting of DMEM (25 mM glucose) supplemented with 10% FBS and 1% penicillin-streptomycin until confluence. Differentiation of myoblasts into myotubes was induced by switching cultures to DMEM supplemented with 2% calf serum and 1% penicillin-streptomycin, as described (19, 20) . At day 6 or 7 days after the initiation of differentiation, myotubes were used for experiments.
C 2C12 myotube contraction by electrical stimulation. On the experimental day, the cells were washed with PBS twice, followed by addition of 2 ml of differentiation medium using DMEM (5.5 mM glucose). After incubation for 1 h at 37°C, the medium was changed to fresh medium again and plates were fitted with 6-well C-Dish electrode and connected to a C-PACE EP Cell Culture Stimulator (Ion Optix, Milton, MA) in order to provide electric pulses of 20 V at 1 Hz for 2 ms at 998-ms intervals for the indicated duration (hours) in an incubator at 37°C, as described by Kanzaki et al. (22) . After the electrical stimulation (ES), conditioned media (CM) were collected and centrifuged at 15,700 g for 10 min to eliminate cell fragments, and the supernatant was used for experiments. Myotube monolayers were harvested for total RNA or protein as described below.
Monocyte migration assay. Regular DMEM medium containing 5.5 mM glucose and supplemented with 2% calf serum and 1% penicillin-streptomycin (RM), or CM from noncontracted or contracted cells, or recombinant proteins in RM (each 550 l), was added to the lower chamber of Boyden chambers (Transwell, 6.5 mm diameter, 5 m pore diameter; Corning, Lowell, MA). THP1monocytes (100 l of 5 ϫ 10 6 cells/ml) in RM were placed in the upper chamber. After 3 h at 37°C, cells were dislodged from the filter by gentle shaking, the upper chamber was discarded, and monocytes that transmigrated were counted in aliquot from the bottom chamber using a Z2 Coulter counter (Beckman Coulter, Mississauga, ON, Canada).
Western blot analysis. Myotube monolayers were lysed with 300 l of ice-cold RIPA lysis buffer (100 mM NaCl, 0.25% wt/vol sodium deoxycholate, 1.0% wt/vol NP-40, 0.1% wt/vol SDS, 2 mM EDTA, 50 mM NaF, 10 nM okadaic acid, 1 mM sodium orthovanadate, protease inhibitor cocktail, and 50 mM Tris·HCl, pH 7.2), and the harvested cells were triturated five times with a 25-gauge syringe and centrifuged at 15,700 g for 15 min, and the supernatant was further processed for immunoblotting.
The protein concentration was determined by the bicinchoninic acid method, and equal amounts of the samples (indicated in the figure legends) were separated by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes. The PVDF membranes were blocked with Tris-buffered saline containing 0.1% Tween 20, 2.5% nonfat dry milk, and 2.5% bovine serum albumin. The membranes were incubated overnight with anti-␤-actin (Sigma-Aldrich) or anti-AMPK␣2, Akt, JNK1/2, ERK1/2, or phospho-AMPK␣ ( RNA isolation and qPCR. All reagents were from ThermoFisher/ Life Technologies (Mississauga, ON, Canada). RNA was isolated using TRIzol (0.5 ml/well l in a 6-well plate), and cDNA was synthesized using the SuperScript VILO cDNA kit according to the manufacturer's protocols. cDNA were used for RT-qPCR using predesigned FAM-MGB-conjugated Taqman probes for target genes, and Abt1-VIC-PL was run in all reaction wells (as an internal housekeeping reference).
ELISA. Levels of mouse IL-6 and CCL2 in conditioned medium were measured with commercially available ELISA Max Deluxe kits (Biolegend, San Diego, CA).
LDH assay. LDH activity in the conditioned medium was measured using a cytotoxicity detection kit following the manufacturer's instructions (Roche, Basel, Switzerland).
Statistical analysis. Data are shown as means Ϯ SE values. For multiple comparisons, data were analyzed using a one-way or twoway ANOVA followed by the Bonferroni post hoc test. The Pearson correlation coefficient (r) and the square (r 2 ) were used for correlation analysis. P Ͻ 0.05 was considered to be significant.
RESULTS
Electrically stimulated myotubes attract monocytes. C 2 C 12 myotubes were induced to contract using an IonOptix C-PACE EP Cell Culture Stimulator with six-well C-Dish electrodes delivering electrical pulses of 20 V, 1 Hz, 2 ms at 998-ms intervals for the indicated duration. Generalized myotube contraction was ascertained by observation under light microscopy and was immediately apparent upon initiation of ES, becoming widely apparent throughout the cultures after 2 h of ES. By 1 h of ES, we observed phosphorylation of kinases typically activated in contracted skeletal muscle (34) (Fig. 1A) . Myotube ES also increased in a time-dependent fashion the mRNA expression (Fig. 1B) and polypeptide secretion of IL-6 (Fig. 1C) , a prototypical myokine induced by contracted skeletal muscle. It was reported that exercise-induced IL-6 expression in skeletal muscle is regulated by JNK (44) . When myotubes were treated with 20 M SP600125, a JNK inhibitor, ES-induced IL-6 expression ( Fig.  1D ) and secretion ( Fig. 1E) were partly inhibited. These findings established that the in vitro model used reproduces exercise-regulated signaling and myokine production and release.
To investigate whether muscle-secreted factors would induce monocyte chemoattraction, C 2 C 12 myotubes were electrically stimulated to contract for 2, 3, 4, and 8 h. Conditioned medium (CM) was collected and supplied to THP-1 monocytes across porous transwells in Boyden chambers to score monocyte migration ( Fig. 2A) . There was no detectable chemoattraction toward CM from myotubes electrically stimulated for up to 3 h (ES-CM) relative to CM from nonstimulated (basal) myotubes (Basal-CM). However, by 4 h and for up to 8 h of stimulation, ES-CM increased monocyte migration significantly compared with Basal-CM ( Fig. 2A) , indicating that secreted factors from in vitro-contracted myotubes can evoke monocyte migration. LDH release, an index of cell damage, did not change significantly for up to 8 h of ES (Fig. 2B ). This suggests that monocyte migration evoked by electrically stimulated myotubes was not mediated by any potential cell damage resulting from ES/mechanical contraction.
The monocyte attractant is a secreted protein. Potential monocyte chemoattractants released by myotubes are nucleo- was measured in nonstimulated (Basal) and 1-h electrically stimulated (ES) C2C12 myotubes. Immunoblotting was performed using specific antibodies to phosphorylated and native forms of the kinases, as indicated. Representative gels with 40 g of protein loaded per lane are illustrated. Protein band densities in images of immunoblots were quantified using Image Studio (LI-COR Biotechnology). Nonpaired t-test was used for statistical analysis. Results are means Ϯ SE; *P Ͻ 0.05, (n ϭ 4 -6 independent experiments). B and C: C2C12 myotubes were electrically stimulated for 1 and 4 h. B: IL-6 mRNA expression in electrically stimulated myotubes was analyzed in duplicate using qPCR (n ϭ 3-5 independent experiments). C: IL-6 protein content in Basal-CM (conditioned medium) and ES-CM was analyzed by ELISA in duplicate (n ϭ 3-6 independent experiments). D and E: C2C12 myotubes were pretreated with 20 M of JNK inhibitor SP600125 (n ϭ 3 experiments) for 1 h and then electrically stimulated for 4 h in the continued presence of the inhibitor. Lysates and CM were then collected for measurements of IL-6 mRNA expression (D) and IL-6 secretion (E). ND, not detectable. Results are means Ϯ SE; *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001. tides and chemokines (4, 22, 37) . To differentiate between them, CM from 4-h basal and contracted myotubes were heat-inactivated or treated with proteinase K (PROK) to denature proteins. CM were also filtered through a 3-kDa cut-off membrane, and the retained (Ͼ3-kDa) and filtered (Ͻ3-kDa) fractions were tested separately for monocyte chemoattracting activity. Heat and PROK treatments of CM, as well as the filtered fraction (Ͻ3-kDa), displayed markedly reduced monocyte chemoattracting activity. This was found with both Basal-CM and ES-CM, and importantly the difference in chemoattracting activity between them was also eliminated (Fig. 3A) . On the other hand, the retained fractions (Ͼ3-kDa) from Basal-CM and ES-CM maintained their respective monocyte migration activities, including the heightened activity of ES-CM (Fig. 3A) . These results suggest that contracted myotubes attract monocytes via secreted protein(s) and not via small, heat-resistant molecules.
CCL2 expression and secretion increase upon ES-induced myotube contraction. It has been reported that myotubes secrete chemokines such as CCL2, CXCL1, and CXCL5 upon contraction (4, 7, 20) . However, the importance of these chemokines on monocyte migration cells is unknown. To begin clarifying which chemokine is necessary for contractioninduced monocyte migration, we measured the mRNA expression in myotubes of CCL2 and CXCL chemokines (CXCL1, -2, -5, and -12) for which monocytes express receptors. CXCL12 mRNA expression in myotubes did not change upon ES/contraction at any time point (Fig. 3B) . On the other hand, within 2 h of contraction, CCL2 mRNA expression was already markedly elevated and remained so for 8 h (Fig. 3B) . The ES-driven expression of CXCL1, CXCL2, and CXCL5 followed a similar time course and pattern as that of CCL2 (Fig. 3B) .
To investigate the potential chemoattracting effect of these chemokines on monocyte migration, recombinant forms of the mouse proteins were supplied to THP-1 monocytes in the transwell migration assay in the absence of CM. Interestingly, only recombinant CCL2 and CXCL12 increased monocyte migration, and this response was dose dependent (Fig. 3C) .
However, CXCL12 expression was not elevated in contracted C 2 C 12 myotubes. Of the other expressed myokines, neither recombinant CXCL1, -2, nor -5 stimulated monocyte migration even at concentrations as high as 100 ng/ml (Fig. 3C) . Therefore, we focused next on CCL2 as the potential monocyte chemoattractant released by contracted myotubes. The concentration of CCL2 detected by ELISA rose in the medium of electrically stimulated myotubes in a time course-dependent fashion, reaching significantly higher levels at 4 h of contraction and continuing to rise at 8 h (Fig. 3D ). CCL2 expression rises in skeletal muscle after eccentric, but not after concentric, exercise (14) . Thus, we hypothesized that induction of CCL2 expression occurs after a threshold of contraction intensity. Consistent with this concept, ES with 20 V induced higher CCL2 expression and secretion compared with ES with 1 or 10 V. Also, it was reported that only high-intensity exercise increases macrophages in skeletal muscles (24, 40) . Together, these findings endorse the concept that monocyte infiltration is induced by CCL2 secreted from electrically stimulated myotubes.
Electrically stimulated myotubes attract monocytes via CCL2. The concentration of CCL2 released by myotubes after 4 h of ES-induced contraction (5.1 ng/ml) was equivalent to the lowest concentrations of recombinant mouse CCL2 that elicited monocyte migration (Fig. 3, C and D) , suggesting that CCL2 could be a relevant contraction-induced monocyte chemokine. To test this prediction, CM from myotubes electrically stimulated for 4 h was preincubated with neutralizing CCL2 antibody or with an IgG isotype control and then supplied to THP-1 monocytes for transwell migration assays in the continued presence of CCL2 antibody or IgG control. Notably, neutralizing CCL2 completely inhibited monocyte migration induced by ES-CM without affecting monocyte migration toward Basal-CM (Fig. 4A) .
To explore the role of CCL2 further, we antagonized the CCL2 receptor, CC chemokine receptor 2 (CCR2), in THP-1 monocytes using RS102895. This small molecule completely abrogated the increase in monocyte migration toward ES-CM (Fig. 4B) . In contrast, AMD3100, an antagonist of CXC Fig. 2 . CM from myotubes electrically stimulated for increasing periods of time promotes monocyte migration. C2C12 myotubes were electrically stimulated to evoke contractions for 2, 3, 4, and 8 h. A: migration of THP1 monocytes toward CM from basal and ES-contracted C2C12 myotubes. results are expressed relative to monocyte migration that occurs with regular medium (RM) alone. Results (n ϭ 3-9 independent experiments) are means Ϯ SE; *P Ͻ 0.05, **P Ͻ 0.01 vs. Basal at each time point. B: LDH release was measured as an index of cell damage. Supernatant from 0.1% Triton X-100-lysed cells was used for total LDH release (dotted line and triangle). Results (n ϭ 3 independent experiments) are means Ϯ SE, and there were no significant differences between Basal-CM and ES-CM at any time point. Data were analyzed using two-way ANOVA followed by the Bonferroni post hoc test. Fig. 3 . CCL2 is the only monocyte chemoattractant that is expressed and released from myotubes in response to ES. CCL, C-C motif ligand; CXCL, C-X-C motif ligand. A: Basal-CM and ES-CM from myotubes were heat inactivated (heated, 95°C, 20 min) or treated with proteinase K (PROK, 100 g/ml, for 1.5 h at 37°C) to denature proteins. Untreated Basal-CM and ES-CM were also filtered through a 3-kDa cut-off membrane, and retained (MW Ͼ 3-kDa) and filtered (MW Ͻ 3-kDa) fractions were tested separately for monocyte chemoattracting activity compared with migration of THP1 monocytes toward 4-h Basal-CM or 4-h ES-CM from C2C12 myotubes (n ϭ 3-5 independent experiments). B: chemokines (CCL2, CXCL1, CXCL2, CXCL5, and CXCL12) mRNA expression in myotubes electrically stimulated for 2, 3, 4, and 8 h was analyzed in duplicate using qPCR (n ϭ 3 independent experiments). Gene expression is shown as 2
⌬CT each in Basal (white symbols) and electrically stimulated group (black symbols). C: recombinant chemokines were tested up to 100 ng/ml for their ability to attract monocytes (n ϭ 3-4 independent experiments). D: CCL2 content in myotube CM after 2, 3, 4, and 8 h culturing without (Basal) or with ES was analyzed by ELISA in duplicate (n ϭ 3 independent experiments). E and F: C2C12 myotubes were electrically stimulated for 4 h with pulses of 1, 10, or 20 V. Then, lysates and CM were collected for measurements of CCL2 mRNA expression (E) and CCL2 secretion (F) (n ϭ 4 independent experiments). Results are means Ϯ SE; *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 vs. Basal in each condition or time point or between each voltage. chemokine receptor 4 (CXCR4, the CXCL12 receptor) did not alter monocyte migration stimulated by either type of CM. This finding suggests that CXCL12 was not present in the CM at concentrations able to induce monocyte migration, consistent with a lack of change in its mRNA expression during myotube contraction (Fig. 4B) . Overall, these results suggest that electrically stimulated contracting myotubes attract monocytes through CCL2 and not CXCL12.
Membrane depolarization, but not mechanical contraction, is necessary for CCL2 expression. CCL2 expression in electrically stimulated contracted myotubes raises the question whether this is brought about by mechanical, contractile activity, or by inducing, electrical depolarization. To approach this question, we inhibited myosin II ATPase in myotubes using BTS (2) during the electrical stimulation period and then analyzed CCL2 expression and secretion. BTS treatment during the ES period completely eliminated myotube contraction when viewed microscopically (results not shown). However, as illustrated in Fig. 5 , BTS treatment did not prevent either CCL2 expression (Fig. 5A) or secretion (Fig. 5B) . These results suggest that ES increased CCL2 expression and secretion independently of the contractile activity of myotubes.
Exercise-or ES-induced membrane depolarization is accompanied by cytosolic calcium increases brought about by calcium efflux from sarcoplasmic reticulum,in both skeletal muscles (1) and C 2 C 12 myotubes (19) . To investigate the effect of cytosolic calcium elevation on CCL2 expression, myotubes were preincubated for 1 h with 15 M BAPTA-AM, a membrane-permeant calcium chelator, and then electrically stimulated for 4 h in the continued presence of BAPTA-AM. These conditions tended to lower ES-induced CCL2 expression (Fig.  5C ) and partially, but significantly, reduced CCL2 secretion (Fig. 5D ) by 41%. We therefore propose that there are membrane depolarization-induced and calcium-dependent and -independent pathways mediating ES-induced CCL2 expression. We also attempted to cause membrane depolarization pharmacologically by treating myotubes for 4 h with 100 M carbachol, an acetylcholine receptor agonist (24) . We previously showed that at this concentration carbachol evokes a transient and pulsatile increase in cytosolic calcium in C 2 C 12 myotubes that diminishes after 20 min (24). However, under the same conditions, carbachol did not induce CCL2 expression or IL-6 expression (data not shown). Similarly, replacing NaCl in the medium by 120 mM K-gluconate, a condition that depolarizes myotubes (45), failed to promote CCL2 expression or IL-6 expression (data not shown). Potentially, the pattern of ES utilized triggers a more profound or more exercise-like membrane depolarization than carbachol or high extracellular K ϩ , and only the ES-induced depolarization suffices to induce CCL2 gene expression.
NF-B activation is required for CCL2 production and ensuing monocyte chemoattraction. NF-B is one of the major transcription factors that induce inflammatory gene expression during exercise, including CCL2 mRNA expression (39, 43) . By 1 h, ES also induced NF-B activation in myotubes in culture, measured by phosphorylation of the p65 subunit of NF-B (Fig. 6A) . JNK is another regulator of inflammatory gene expression, mediated by the transcription factor AP-1 (44) . To investigate whether JNK or NF-B activation mediate ES-stimulated CCL2 expression, myotubes were pretreated with the JNK inhibitor SP600125 or the NF-B inhibitors caffeic acid phenethyl ester (CAPE) or cardamonin (Card) prior to and during 4 h of ES. Treatment with SP600125 lowered ES-induced CCL2 expression by only 34% (Fig. 6B ) compared with an 86% reduction by CAPE or 46% by Card. Therefore, NF-B emerged as a major regulator of CCL2 expression and was analyzed in subsequent experiments. The two NF-B inhibitors reduced ES-induced CCL2 secretion (Fig. 6, D and G) . In contrast, ES-induced IL-6 expression was inhibited by Card but not by CAPE (data not shown).
Consistent with their effect on CCL2 expression, ES-CMinduced monocyte migration was completely inhibited by myotube pretreatment with the CAPE or Card (Fig. 6, E and H) . It should be noted that, at the doses used, neither NF-B inhibitor affected myotube contractile activity. Together, these findings indicate that ES induces NF-B activation that mediates the expression of CCL2, required for the monocyte chemoattracting ability of electrically stimulated myotubes. Correlation between myotube-secreted CCL2 levels and monocyte chemoattraction. The relationship between monocyte migration and CCL2 protein concentration in ES-CM across all conditions used in this study is illustrated in Fig. 7 . In this scatter plot each point within a group represents the mean from each of seven specified conditions (CM from myotubes electrically stimulated for 2, 3, 4, or 8 h or from myotubes stimulated for 4 h in the presence of DMSO vehicle, CAPE, or Card). Analysis of the seven mean values yielded a positive correlation coefficient (r ϭ 0.7810) and coefficient of determination (r 2 ) of 0.6100 between the CCL2 concentration in the CM and monocyte chemoattraction. This analysis lends strong support to the concept that CCL2 from electrically stimulated myotubes drives monocyte migration. We propose a model whereby ES of myotubes promotes NF-B -mediated gene expression of CCL2. By 4 h of continuous contraction, sufficient CCL2 protein is released from the myotube cultures and has accumulated to stimulate monocyte migration (Fig. 8) .
DISCUSSION
Low-grade muscle inflammation arises after exercise activity, characterized by gene expression of inflammatory cytokines. This is particularly noticeable after high-intensity exercise, such as downhill treadmill running and resistance exercise, in both humans and rodents (3, 39, 43, 46) . In most cases, muscle inflammation is characterized by elevated activity of the NF-B pathway within muscle extracts, although it is not possible to ascribe the response to a particular cell type within the muscle tissue. Within 2-24 h of such exercise programs, the macrophage number within skeletal muscle tissue increases and may stay elevated for over 1 wk (16, 27, 46) . Although skeletal muscle normally contains resident macrophages, it is likely that exercise causes a gain in macrophage precursors (monocytes). This is supported by the fact that treatment in mice with clodronate-containing liposomes, a reagent to deplete circulating monocytes, prevented the gain in macrophage numbers within muscle following treadmill running yet did not affect macrophage numbers in the muscle of nonexercised control animals (16) .
It is unknown whether muscle cells or other cells within the tissue emit such attractants. To begin to address this question, we have established a cellular system of contracting myotubes and explored their ability to attract monocytes. C 2 C 12 myotubes have been previously used as a bona fide culture system that can mount a contractile response to electrical stimulation.
Our findings reveal that CM from electrically stimulated, contracting myotubes caused robust chemoattraction of THP-1 monocytes across transwell Boyden chambers. Myotubes may express several monocyte chemoattracting molecules; thus, we first used heat inactivation, protease sensitivity, and filtration and narrowed down the potential attractants to protein factors rather than small molecules such as nucleotides. We found that gene expression of several putative monocyte chemokines were elevated in C 2 C 12 myotube cultures following electrically induced contraction and discriminated that CCL2 is the most relevant one, as follows. First, electrically stimulated contracting myotubes released CCL2 into the medium at concentrations equaling those of recombinant mouse CCL2 that independently evoke monocyte migration in transwells. Second, a CCL2 neutralizing antibody eliminated the ability of CM collected from electrically stimulated myotubes to promote monocyte migration. Third, a CCR2 receptor antagonist administered to monocytes blocked their migration toward CM from the contracting myotubes. We further demonstrated that CCL2 expression and secretion is a direct response to ES and not to the ensuing myotube contraction. Moreover, ES activated NF-B within myotubes. These findings open the door to unraveling the signals linking membrane depolarization to activation of this signaling program. These signals include both calcium-dependent and -independent pathways, because the effect of BAPTA-AM on ES-induced CCL2 secretion was only partial. Future studies are needed to determine how NF-B and JNK are activated by contraction. To our knowledge, this is the first demonstration that electrically stimulated contracting myotubes mount an activation of this cell-intrinsic pathway and suggest that the elevated NF-B expression detected in muscle extracts of exercised muscle may reflect activation of the proinflammatory program within muscle cells themselves.
The culminating observation of our study is that the activated NF-B pathway leads to expression of CCL2 that, once secreted to the medium, enacts monocyte chemoattraction. This was evinced using two distinct inhibitors of the NF-B pathway, which we found reduced ES-induced CCL2 gene expression and polypeptide secretion into the culture medium. Moreover, CM from myotubes treated with these NF-B inhibitors during ES no longer stimulated monocyte migration, buttressing the concept that CCL2 plays an important role in the monocyte migration response to CM from electrically stimulated myotubes. Interestingly, the ES-induced expression of the major myokine IL-6 was not inhibited by CAPE, yet this NF-B inhibitor abolished monocyte chemoattraction toward ES-CM. This suggests that IL-6 expression per se may not suffice for ES-induced chemoattraction.
Overall, a strong correlation was observed across experimental conditions, for the relationship between CCL2 levels in CM from electrically stimulated contracting myotubes with the ability of the CM to induce monocyte migration across experimental conditions (r 2 ϭ 0.61). Thus, contracting myotubes release sufficient CCL2 that independently and effectively stimulates monocyte migration. These findings have implications for the chemoattracting activity of exercised skeletal muscle in vivo, since both CCL2 expression in skeletal muscle and its concentration in the circulation rise after exercise (6) .
Diversity of muscle chemokines and their participation in immune cell chemoattraction. Secreted proteins having chemoattracting activity comprise chemokines that broadly belong to the CC or CXC families (7). We recently found C 2 C 12 myotubes secrete macrophage migration inhibitory factor (MIF) (20) , a non-chemokine that is also known to attract monocytes, yet its secretion was actually reduced by ES, making it an unlikely contributor to monocyte chemoattraction in this setting. It is also reported that, following contraction, myotubes secrete the monocyte-targeting chemokines CXCL1 and -5 (23) and monocytes express receptors for CXCL2 and -12 (12) . Although ES induced gene expression of CXCL1, -2, and -5 in our system of contracting C 2 C 12 myotubes, the recombinant murine forms of these gene products had no effect on monocyte migration. Furthermore, ES did not elevate CXCL12 expression. Human CXCL6, the homolog of murine CXCL5, rather attracts neutrophils (11), a response implicated in muscle regeneration from injury (42) . From this analysis, secretion of CXCL chemokines may increase upon myotube contraction and might have physiological action distinct from monocyte migration. Recombinant human CXCL2 and -3, the homologs of murine CXCL1 and -2, actually arrested human monocyte movement, an important means to halt monocyte rolling on endothelial cells at sites of inflammation, necessary for monocyte infiltration of tissues (40) . These findings distill CCL2 as the prominent chemokine released by electrically stimulated, contracting C 2 C 12 myotubes that enacts monocyte chemoattraction.
As stated above, exercise in vivo can increase both CCL2 expression in skeletal muscle and CCL2 concentration in the circulation (6) . The source of CCL2 is unclear, since skeletal muscle comprises several cell types. Cellular studies can better identify the muscle cell origin of CCL2 upon contraction, and earlier studies have shown that myotubes secrete CCL2 by 24 h of contraction (elicited by a different program of electrical pulses from that used herein). Under those conditions, the increase in secreted CCL2 was only 1.5-fold compared with basal conditions (32) , and its functional implications were not analyzed. With our ES program, a robust increase of CCL2 secretion (Ͼ30-fold) was observed by 4 h while preserving cellular integrity. Therefore, myotubes have the capacity to secrete high levels of CCL2 under specific ES/contraction programs.
Exercise-induced activation of NF-B within skeletal muscle. Several studies have shown an exercise-induced activation of NF-B pathway in skeletal muscle (39, 41, 43, 46) , but there are also a few opposing reports reporting suppression of this pathway (38) . Exercise can increase NF-B p65 binding to the promoter of CCL2 in skeletal muscle and an NF-B inhibitor quenched exercise-induced CCL2 expression (39, 43) . However, it is not entirely clear that NF-B was activated in myofibers themselves. In fact, after 3 h of eccentric exercise, a robust increase in immunostaining of phosphorylated NF-B p65 was observed in muscle tissue pericytes but not in muscle fiber nuclei (15) . In our study, NF-B was activated within myotubes by 1 h of ES (Fig. 6A) , but diminished by 4 h even with continued ES inducing contraction. Although it is not possible to equate the contraction protocol imposed on myotubes in culture to the exercise program imposed in vivo, it is plausible that NF-B activation within myofibers occurs at earlier times than those analyzed in vivo, and/or that response is far lower than in pericytes. Our study demonstrates NF-B activation within the contracting myotubes.
Implication of our findings for monocyte chemoattraction toward muscle in other physiological conditions. Muscle injury triggers a rapid proinflammatory response that is pivotal for the complex process of tissue regeneration. Injured muscle gains macrophages largely through the infiltration of monocytes, ascribed in large part to the chemoattracting activity of CCL2 (18) . In this context, infiltrating monocytes first acquire an M1 polarization (proinflammatory) that aid in satellite cell activation and myoblast proliferation. Subsequently, M1 macrophages transition toward the M2 anti-inflammatory polarization that clear muscle cell debris, repress myoblast proliferation, and promote myoblast fusion into myotubes (29, 35) . Likewise, M2 macrophage numbers increase within muscle by 24 -72 h after exercise in both humans and mice (16, 31) .
Importantly, M1 macrophages confer insulin resistance to adipose and skeletal muscles (26) , whereas M2 macrophages improve insulin sensitivity in skeletal muscles (13, 16, 25) . Of note, clodronate-induced depletion of circulating monocytes repressed the increase of M2 macrophages in skeletal muscles upon exercise, and this correlated with the inhibition of exercise-induced enhancement of insulin sensitization (16) . While suggesting that monocytes recruited to exercised muscles may acquire M2 polarization to contribute to promoting insulin sensitivity and enhancing anabolism, it cannot be discounted that macrophage depletion in other tissues may have also influenced insulin sensitivity in this experiment. Future studies should clarify the contribution of M2 macrophages to the enhanced muscle insulin sensitivity elicited by exercise.
In conclusion, we report an NF-B-dependent elevation of CCL2 release from electrically stimulated contracting C 2 C 12 myotubes that responds to the myotube electrical activity rather than mechanical contraction. These findings raise the possibility that, in vivo, contracting muscle fibers may also release CCL2 through an NF-B-regulated response to promote monocyte infiltration of skeletal muscle. This could have implications for macrophage polarization during postexercise recovery and muscle regeneration as well as for the postexercise increase in muscle insulin sensitivity.
